secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K
Filed at:   2026-06-17T20:32:20+00:00
Accession:  0001731122-26-000871
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lunai Bioworks lands first defense contract, sues naked short sellers over 81.6% FTD shares
--------------------------------------------------------------------------------

- Secured first revenue-generating multi-year defense collaboration via BioSymetrics for chemical threat assessment.
- Formed Pathfinder Consortium with Harvard, Brigham & Women's, Purdue, Utah, Colorado for biodefense.
- Partnered with BrainStorm Therapeutics; awarded $1.85M NIH STTR grant for alcohol use disorder.
- Filed May 2026 lawsuit against unidentified parties; 29.6M fails-to-deliver (81.6% of shares); court granted expedited discovery.
- Achieved compliance with Nasdaq listing requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112226000871/0001731122-26-000871-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112226000871/e7731_8k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-26-000871

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer